Saltar al contenido
Merck

Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin.

Antimicrobial agents and chemotherapy (2012-05-23)
Dea Shahinas, Gregory Macmullin, Christan Benedict, Ian Crandall, Dylan R Pillai
RESUMEN

Previous studies have shown an antimalarial effect of total alkaloids extracted from leaves of Guiera senegalensis from Mali in West Africa. We independently observed that the beta-carboline alkaloid harmine obtained from a natural product library screen inhibited Plasmodium falciparum heat shock protein 90 (PfHsp90) ATP-binding domain. In this study, we confirmed harmine-PfHsp90-specific affinity using surface plasmon resonance analysis (dissociation constant [K(d)] of 40 μM). In contrast, the related compound harmalol bound human Hsp90 (HsHsp90) (K(d) of 224 μM) more tightly than PfHsp90 (K(d) of 7,010 μM). Site-directed mutagenesis revealed that Arg98 in PfHsp90 is essential for harmine selectivity. In keeping with our model indicating that Hsp90 inhibition affords synergistic combinations with existing antimalarials, we demonstrated that harmine potentiates the effect of chloroquine and artemisinin in vitro and in the Plasmodium berghei mouse model. These findings have implications for the development of novel therapeutic combinations that are synergistic with existing antimalarials.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Harmaline, ≥95%